These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24304586)

  • 1. Phenolic esters of O-desmethylvenlafaxine with improved oral bioavailability and brain uptake.
    Zhang Y; Yang Y; Zhao S; Yang Z; Yang H; Fawcett JP; Li Y; Gu J; Sun T
    Molecules; 2013 Dec; 18(12):14920-34. PubMed ID: 24304586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel prodrug strategy to improve the oral absorption of O-desmethylvenlafaxine.
    Liu M; Sun Y; Zhao S; Li Y; Piao R; Yang Y; Gu J
    Exp Ther Med; 2016 Sep; 12(3):1611-1617. PubMed ID: 27588083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of venlafaxine and O-desmethylvenlafaxine in laboratory animals.
    Howell SR; Hicks DR; Scatina JA; Sisenwine SF
    Xenobiotica; 1994 Apr; 24(4):315-27. PubMed ID: 8059535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential outcomes from metabolic ratios in the identification of CYP2D6 phenotypes--focus on venlafaxine and O-desmethylvenlafaxine.
    Kandasamy M; Srinivas P; Subramaniam K; Ravi S; John J; Shekar R; Srinivas N; Thangam S
    Eur J Clin Pharmacol; 2010 Sep; 66(9):879-87. PubMed ID: 20446083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of venlafaxine, O-desmethylvenlafaxine, and O-desmethylvenlafaxine to venlafaxine ratio in postmortem human brain tissue.
    Murrell MD; Cruz DA; Javors MA; Thompson PM
    J Forensic Sci; 2014 May; 59(3):683-9. PubMed ID: 24502274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open-label positron emission tomography study to evaluate serotonin transporter occupancy following escalating dosing regimens of (R)-(-)-O-desmethylvenlafaxine and racemic O-desmethylvenlafaxine.
    Frankle WG; Robertson B; Maier G; Paris J; Asmonga D; May M; Himes ML; Mason NS; Mathis CA; Narendran R
    Synapse; 2018 Mar; 72(3):. PubMed ID: 29216407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid determination of venlafaxine and O-desmethylvenlafaxine in human plasma by high-performance liquid chromatography with fluorimetric detection.
    Vu RL; Helmeste D; Albers L; Reist C
    J Chromatogr B Biomed Sci Appl; 1997 Dec; 703(1-2):195-201. PubMed ID: 9448076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect Of Chinese Herb Danzhi Xiaoyao Pills On Pharmacokinetics Of Venlafaxine In Beagles.
    Zhu YL; Li SL; Chen KL; Ma KP; Wu DQ; Qiu XJ
    Drug Des Devel Ther; 2019; 13():3343-3355. PubMed ID: 31571835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo evaluations of the metabolism, pharmacokinetics, and bioavailability of ester prodrugs of L-767,679, a potent fibrinogen receptor antagonist: an approach for the selection of a prodrug candidate.
    Prueksaritanont T; Gorham LM; Breslin MJ; Hutchinson JH; Hartman GD; Vyas KP; Baillie TA
    Drug Metab Dispos; 1997 Aug; 25(8):978-84. PubMed ID: 9280406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism and pharmacokinetics of novel oral prodrugs of 9-[(R)-2-(phosphonomethoxy)propyl]adenine (PMPA) in dogs.
    Shaw JP; Sueoko CM; Oliyai R; Lee WA; Arimilli MN; Kim CU; Cundy KC
    Pharm Res; 1997 Dec; 14(12):1824-9. PubMed ID: 9453075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time course of clinical response to venlafaxine: relevance of plasma level and chirality.
    Gex-Fabry M; Balant-Gorgia AE; Balant LP; Rudaz S; Veuthey JL; Bertschy G
    Eur J Clin Pharmacol; 2004 Feb; 59(12):883-91. PubMed ID: 14704834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution and excretion of venlafaxine and O-desmethylvenlafaxine in human milk.
    Ilett KF; Hackett LP; Dusci LJ; Roberts MJ; Kristensen JH; Paech M; Groves A; Yapp P
    Br J Clin Pharmacol; 1998 May; 45(5):459-62. PubMed ID: 9643618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venlafaxine metabolism as a marker of cytochrome P450 enzyme 2D6 metabolizer status.
    Nichols AI; Lobello K; Guico-Pabia CJ; Paul J; Preskorn SH
    J Clin Psychopharmacol; 2009 Aug; 29(4):383-6. PubMed ID: 19593180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of venlafaxine extended release 75  mg and desvenlafaxine 50  mg in healthy CYP2D6 extensive and poor metabolizers: a randomized, open-label, two-period, parallel-group, crossover study.
    Nichols AI; Focht K; Jiang Q; Preskorn SH; Kane CP
    Clin Drug Investig; 2011; 31(3):155-67. PubMed ID: 21288052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A high-performance liquid chromatographic method for the simultaneous determination of venlafaxine and O-desmethylvenlafaxine in biological fluids.
    Hicks DR; Wolaniuk D; Russell A; Cavanaugh N; Kraml M
    Ther Drug Monit; 1994 Feb; 16(1):100-7. PubMed ID: 8160247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence and removal of lidocaine, tramadol, venlafaxine, and their metabolites in German wastewater treatment plants.
    Rúa-Gómez PC; Püttmann W
    Environ Sci Pollut Res Int; 2012 Mar; 19(3):689-99. PubMed ID: 21909967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic drug monitoring of racemic venlafaxine and its main metabolites in an everyday clinical setting.
    Reis M; Lundmark J; Björk H; Bengtsson F
    Ther Drug Monit; 2002 Aug; 24(4):545-53. PubMed ID: 12142641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steady-state concentration of venlafaxine enantiomers: model-based analysis of between-patient variability.
    Gex-Fabry M; Rudaz S; Balant-Gorgia AE; Brachet A; Veuthey JL; Balant LP; Bertschy G
    Eur J Clin Pharmacol; 2002 Aug; 58(5):323-31. PubMed ID: 12185556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal forms of the hydrogen oxalate salt of o-desmethylvenlafaxine.
    Dichiarante E; Curzi M; Giaffreda SL; Grepioni F; Maini L; Braga D
    J Pharm Pharmacol; 2015 Jun; 67(6):823-9. PubMed ID: 25644936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishing bioequivalence of racemic venlafaxine formulations using stereoselective assay method: Is it necessary?
    Kandhwal K; Dey S; Nazarudheen S; Reyar S; Mishra S; Thudi NR; Khuroo AH; Monif T
    Chirality; 2011 Nov; 23(10):948-54. PubMed ID: 21953854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.